Results 151 to 160 of about 26,462 (230)

Knockout of P2Y12 receptor facilitates neuronal envelopment by reactive microglia and accelerates prion disease. [PDF]

J Neuroinflammation
Makarava N, Safadi T, Bocharova O, Mychko O, Pandit NP, Molesworth K, Eyo UB, Baskakov IV.   +7 more
europepmc   +1 more source

GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists. [PDF]

J Clin Med, 2022
Kanic V, Kompara G, Suran D.
europepmc   +1 more source

The Extended Safety and Efficacy of Indobufen in Conjunction With P2Y12 Receptor Inhibitors Among Patients Undergoing Revascularization: A Meta-Analysis and Overview. [PDF]

Cardiovasc Ther
Yi M, Cao Q, Sheng YH, Wu L, Ke X.
europepmc   +1 more source

Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the Brain. [PDF]

J Med Chem
Joseph E, Kunze LH, Schaefer R, Palumbo G, Kugelmann B, Wagner S, Lammich S, Feederle R, Willem M, Werner RA, Brendel M, Lindner S.   +11 more
europepmc   +1 more source

Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor. [PDF]

Pharmaceutics, 2021
Haghighi F, Yesylevskyy S, Davani S, Ramseyer C.   +3 more
europepmc   +1 more source

The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction. [PDF]

Korean J Intern Med, 2022
Park KH, Jeong MH, Kim HK, Ki YJ, Kim SS, Ahn Y, Kook HY, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY, KAMIR-NIH registry investigators.   +26 more
europepmc   +1 more source

Structural and functional evolution of the P2Y12-like receptor group [PDF]

, 2007
Torsten Schöneberg, Thomas Hermsdorf, Eva Engemaier, Kathrin Engel, Ines Liebscher, Doreen Thor, Klaas Zierau, Holger Römpler, Angela Schulz, R Fredriksson, I Kugelgen von, KA Jacobson, BF King, TK Harden, GK Akbar, Q Li, TE Webb, T Yokomizo, Y Nonaka, EA Mellor, EA Mellor, L Mamedova, N Nomura, ME Charlton, JK Chambers, CJ Foster, G Hollopeter, J Takasaki, FL Zhang, D Communi, FL Zhang, F Marteau, M Chhatriwala, A Marchese, T Schoneberg, DK Lee, T Wittenberger, KA Jacobs, T Sugo, P Mombaerts, A Schulz, E Engemaier, SW Roy, KY Song, C Rabadan-Diehl, MP Abbracchio, S Costanzi, H Rompler, H Rompler, K Sangkuhl, T Muller, S Offermanns, M Fumagalli, E Kostenis, BR Conklin, H Ko, MH Pausch, LA Price, X Zhong, MH Pausch, AD Ault, Z Ding, P Andre, SE Haynes, T Schoneberg, JA Remijn, M Shiraga, M Cattaneo, P Fontana, P Fontana, IT Schettert, S Ziegler, International HapMap Consortium, M Bamshad, R Nielsen, R Nielsen, K Tang, R Kimura, T Joensuu, A Bedard, JA Ballesteros   +80 more
core   +1 more source

Correction to: Role and recent progress of P2Y12 receptor in cancer development. [PDF]

Purinergic Signal
Xi Y, Min Z, Liu M, Lin X, Yuan ZH.
europepmc   +1 more source

Correction to: Involvement of P2Y12 receptor of stellate ganglion in diabetic cardiovascular autonomic neuropathy. [PDF]

Purinergic Signal, 2021
Guo J, Sheng X, Dan Y, Xu Y, Zhang Y, Ji H, Wang J, Xu Z, Che H, Li G, Liang S, Li G.   +11 more
europepmc   +1 more source

Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint. [PDF]

Cardiol J
Kubica J, Adamski P, Gajda R, Kubica A, Ostrowska M, Casu G, Gorog DA, Gurbel PA, Hajdukiewicz T, Jaguszewski M, Jeong YH, Kosobucka-Ozdoba A, Motovska Z, Niezgoda P, Piasecki M, Podhajski P, Raggi P, Rahimov U, Siller-Matula JM, Skonieczny G, Szarpak Ł, Szymański P, Tantry U, Navarese EP.   +23 more
europepmc   +1 more source